COP1 and neoplasm: According to the data, deleting E3 ubiquitin ligase Cop1 in cancer cells leads to a decrease in macrophage-associated chemokines, a reduction in tumor macrophage infiltration, enhanced anti-tumor immunity, and a stronger ICI response.